ATYPICAL TERATOID/RHABDOID TUMOR
Clinical trials for ATYPICAL TERATOID/RHABDOID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ATYPICAL TERATOID/RHABDOID TUMOR trials appear
Sign up with your email to follow new studies for ATYPICAL TERATOID/RHABDOID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill combo offers hope for kids with tough cancers
Disease control Recruiting nowThis study is testing a new combination of two oral drugs, AMXT 1501 and eflornithine (DFMO), for children and young adults with certain hard-to-treat cancers that have come back or not responded to standard treatments. The first part of the study aims to find the safest and most…
Matched conditions: ATYPICAL TERATOID/RHABDOID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Apr 04, 2026 02:06 UTC
-
New hope for tots with aggressive brain tumors
Disease control Recruiting nowThis study is testing a new, intensive chemotherapy plan for children under 6 with high-risk brain tumors. The goal is to see if adding a special spinal fluid chemotherapy and a long period of oral 'maintenance' drugs is a workable way to control the cancer. The study will enroll…
Matched conditions: ATYPICAL TERATOID/RHABDOID TUMOR
Phase: EARLY_PHASE1 • Sponsor: C17 Council • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New hope for kids with devastating rare cancers
Disease control Recruiting nowThis study is testing a combination of three drugs—tazemetostat, nivolumab, and ipilimumab—as a potential treatment for children and young adults with rare, aggressive cancers caused by missing specific proteins (INI1 or SMARCA4). The first part aims to find the safest dose, and …
Matched conditions: ATYPICAL TERATOID/RHABDOID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Susan Chi, MD • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Doctors test Direct-to-Brain cell therapy for Kids' devastating tumors
Disease control Recruiting nowThis early-stage study is testing a new cell therapy for children and young adults with aggressive or returning brain tumors. Doctors collect a patient's own immune cells, engineer them in a lab to target a protein (B7H3) found on tumor cells, and then deliver these 'CAR T cells'…
Matched conditions: ATYPICAL TERATOID/RHABDOID TUMOR
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New hope for kids with aggressive brain tumors: pioneering therapy delivered directly to the brain
Disease control Recruiting nowThis early-stage study is testing a new type of personalized immune therapy called B7-H3-CAR T cells for children and young adults (up to age 21) with brain tumors that have come back or haven't responded to standard treatments. The therapy involves collecting a patient's own imm…
Matched conditions: ATYPICAL TERATOID/RHABDOID TUMOR
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC